Literature DB >> 15936548

A screening questionnaire for voice problems after treatment of early glottic cancer.

Christine D L van Gogh1, Irma M Verdonck-de Leeuw, Brigitte A Boon-Kamma, Johannes A Langendijk, Dirk J Kuik, Hans F Mahieu.   

Abstract

PURPOSE: After treatment for early glottic cancer, a considerable number of patients end up with voice problems interfering with daily life activities. A 5-item screening questionnaire was designed for detection of voice impairment. The purpose of this study is to assess psychometric properties of this questionnaire in clinical practice. METHODS AND MATERIALS: The questionnaire was completed by 110 controls without voice complaints and 177 patients after radiotherapy or laser surgery for early glottic cancer.
RESULTS: Based on normative data of the controls, a score of 5 or less on at least 1 of the 5 questions was considered to state overall voice impairment. Reliability of the questionnaire proved to be good. Voice impairment was reported in 44% of the patients treated with radiotherapy vs. 29% of the patients treated with endoscopic laser surgery.
CONCLUSIONS: The questionnaire proved to be a reliable, valid, and feasible method to detect voice impairment in daily life. The questionnaire is easy to fill in, and interpretation is straightforward. It is useful for both radiation oncologists and otorhinolaryngologists in their follow-up of patients treated for early glottic cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15936548     DOI: 10.1016/j.ijrobp.2004.10.027

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Exploring the feasibility of the combination of acoustic voice quality index and glottal function index for voice pathology screening.

Authors:  Nora Ulozaite-Staniene; Tadas Petrauskas; Viktoras Šaferis; Virgilijus Uloza
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-04-23       Impact factor: 2.503

2.  High-speed videolaryngoscopy in early glottic carcinoma patients following transoral CO2 LASER cordectomy.

Authors:  Sachin Gandhi; Subash Bhatta; Dushyanth Ganesuni; Asheesh Dora Ghanpur; Shraddha Jayant Saindani
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-21       Impact factor: 2.503

Review 3.  Voice-Related Patient-Reported Outcome Measures: A Systematic Review of Instrument Development and Validation.

Authors:  David O Francis; James J Daniero; Kristen L Hovis; Nila Sathe; Barbara Jacobson; David F Penson; Irene D Feurer; Melissa L McPheeters
Journal:  J Speech Lang Hear Res       Date:  2017-01-01       Impact factor: 2.297

Review 4.  A systematic review of head and neck cancer quality of life assessment instruments.

Authors:  Bukola Ojo; Eric M Genden; Marita S Teng; Kathrin Milbury; Krzysztof J Misiukiewicz; Hoda Badr
Journal:  Oral Oncol       Date:  2012-04-21       Impact factor: 5.337

5.  Voice in early glottic cancer compared to benign voice pathology.

Authors:  C D L Van Gogh; H F Mahieu; D J Kuik; R N P M Rinkel; J A Langendijk; I M Verdonck-de Leeuw
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-04-25       Impact factor: 2.503

6.  Evaluation of lasersurgery and radiotherapy as treatment modalities in early stage laryngeal carcinoma: tumour outcome and quality of voice.

Authors:  A J Remmelts; F J P Hoebers; W M C Klop; A J M Balm; O Hamming-Vrieze; M W M van den Brekel
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-09       Impact factor: 2.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.